Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit V Khera

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Nature Communications|May 15, 2023
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapyLisa N Kasiewicz, Souvik Biswas, Aaron Beach, et al.
Nature Genetics|July 18, 2017
Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery diseaseDerek Klarin, Qiuyu Martin Zhu, Connor A Emdin, et al.
European Heart Journal|March 19, 2011
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levelsNehal N Mehta, Mingyao Li, Dilusha William, et al.
JAMA Network Open|April 30, 2020
Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family HistoryAniruddh P Patel, Minxian Wang, Akl C Fahed, et al.
Cell Genomics|December 27, 2021
Machine learning enables new insights into genetic contributions to liver fat accumulationMary E Haas, James P Pirruccello, Samuel N Friedman, et al.
Nature Communications|August 22, 2020
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditionsAkl C Fahed, Minxian Wang, Julian R Homburger, et al.
American Journal of Preventive Cardiology|November 28, 2022
Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) WorkshopAnn Marie Navar, Lawrence J Fine, Walter T Ambrosius, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care BiobankJianfeng Xu, Zhuqing Shi, Sumeet A Khetarpal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic testDeanna G Brockman, Christina A Austin-Tse, Renée C Pelletier, et al.
Circulation. Genomic and Precision Medicine|October 1, 2021
Rare, Damaging DNA Variants in <i>CORIN</i> and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing AnalysesMinxian Wang, Vivian S Lee-Kim, Deepak S Atri, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Nature Communications|May 15, 2023
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapyLisa N Kasiewicz, Souvik Biswas, Aaron Beach, et al.
Nature Genetics|July 18, 2017
Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery diseaseDerek Klarin, Qiuyu Martin Zhu, Connor A Emdin, et al.
European Heart Journal|March 19, 2011
The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levelsNehal N Mehta, Mingyao Li, Dilusha William, et al.
JAMA Network Open|April 30, 2020
Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family HistoryAniruddh P Patel, Minxian Wang, Akl C Fahed, et al.
Cell Genomics|December 27, 2021
Machine learning enables new insights into genetic contributions to liver fat accumulationMary E Haas, James P Pirruccello, Samuel N Friedman, et al.
Nature Communications|August 22, 2020
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditionsAkl C Fahed, Minxian Wang, Julian R Homburger, et al.
American Journal of Preventive Cardiology|November 28, 2022
Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) WorkshopAnn Marie Navar, Lawrence J Fine, Walter T Ambrosius, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care BiobankJianfeng Xu, Zhuqing Shi, Sumeet A Khetarpal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic testDeanna G Brockman, Christina A Austin-Tse, Renée C Pelletier, et al.
Circulation. Genomic and Precision Medicine|October 1, 2021
Rare, Damaging DNA Variants in <i>CORIN</i> and Risk of Coronary Artery Disease: Insights From Functional Genomics and Large-Scale Sequencing AnalysesMinxian Wang, Vivian S Lee-Kim, Deepak S Atri, et al.
Pageof 14